Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg

Ozempic® (semaglutide) injection has emerged as a promising therapy. Developed by Novo Nordisk, Ozempic® is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for the treatment of type 2 diabetes mellitus. With its effectiveness, convenience, and potential to revolutionize diabetes care, Ozempic In Dubai has garnered significant attention in the medical community.